Published in Drug Week, June 22nd, 2007
R. Kevin Plemmons, President and CEO of Ostial Solutions LLC, said his firm expects to begin marketing the Ostial Pro Stent Positioning System by mid-June
"The Ostial Pro Stent Positioning System has very broad applications," said Plemmons, who received word of the FDA approval in late May. "We estimated that the device can be used in 90% to 95% of all renal aorta-ostial procedures and 7% of all coronary aorta-ostial...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.